ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1394	National Cancer Institute	Html	en	Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of pancreatic neuroendocrine tumors (islet cell tumors).	patient selection factors 0.438228 tumor cell types 0.413939 functional tumors 0.556939 slow-growing tumors 0.428195 pituitary tumors 0.418826 functional pancreatic neuroendocrine 0.426256 islet cell tumors 0.811481 preoperative dual-phase thin-section 0.348132 bone metastases 0.398217 islet cell cancers 0.399777 distinctive metabolic effects 0.341484 secondary endocrine tumors 0.452606 liver metastases 0.990586 unresectable liver metastases 0.497768 endocrine pancreas glands 0.386 metastatic disease 0.427564 sporadic islet cell 0.397131 resectable liver metastases 0.506505 venous sampling 0.390094 surgical resection series 0.389796 visible liver metastases 0.615044 liver neuroendocrine metastases 0.512043 individual tumors 0.388972 progressive pancreatic NETs 0.411807 clinical manifestations 0.349816	percutaneous alcohol ablation 0.339566 antihormonal pharmacologic therapy 0.339279 conventional imaging techniques 0.33881 radiofrequency ablation 0.342021 pancreatic resection 0.466639 pancreatic islets 0.36916 ulcer-producing Zollinger-Ellison syndrome 0.354188 somatostatin-receptor scintigraphy 0.356211 slow-growing metastatic islet 0.423125 pancreatic NETs 0.575547 technically demanding tests 0.350314 multiple endocrine neoplasia 0.362304 retrospective case series 0.340498 hormonally functional tumors 0.47568 tumor suppressor gene 0.392672 pancreatic islet cell 0.465855 overall tumor burden 0.363718 grossly visible liver 0.505977 MEN-1 syndrome 0.346786 pancreatic neuroendocrine tumors 0.701933 liver resection 0.37949 arterial stimulation 0.345171 common exocrine adenocarcinomas 0.348715 preoperative localization studies 0.4603	CLICK HERE
1554	National Cancer Institute	Html	en	Chronic Lymphocytic Leukemia Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.	red blood cells 0.517668 cancer treatment 0.431205 malignant tumor cells 0.395015 blood -forming cells 0.386238 body 0.377277 PDQ cancer information 0.428983 clinical trial search 0.381057 white blood cells 0.437124 clinical trials 0.679889 mature blood cells 0.419721 Natural killer cells 0.383894 cancer information summary 0.40184 clinical trial 0.489229 lymphocytes 0.390185 Lymphoblastic Leukemia Treatment 0.406769 Myeloid Leukemia Treatment 0.391192 blood cells 0.552101 immature cells 0.367988 treatment clinical trial 0.370422 IgVH gene mutation 0.385864 Cell Leukemia Treatment 0.388308 NCI PDQ cancer 0.372246 lymph nodes 0.416068 Treatment Editorial Board 0.376334	radiation therapy 0.372299 tyrosine kinase inhibitor 0.394203 treatment 0.577005 stored stem cells 0.374171 myeloid stem cell 0.372796 immature blood cells 0.385722 cancer cells 0.498635 lymphoid stem cell 0.371902 specific cancer cells 0.395788 Lymphocytic Leukemia Treatment 0.392931 treatment clinical trials 0.392666 Acute Lymphoblastic Leukemia 0.387556 blood stem cells 0.421035 National Cancer Institute 0.439036 normal cells 0.375452 new treatment 0.432006 bone marrow 0.466319 chronic lymphocytic leukemia 0.905376 cells 0.56649 cancer clinical trials 0.397834 cancer 0.596361 Myelogenous Leukemia Treatment 0.383031 standard treatment 0.368392 Leukemia Treatment 0.421626	CLICK HERE
1623	National Cancer Institute	Html	null	Gonzalez Regimen (PDQ®)–Health Professional Version	The Gonzalez regimen is a specialized diet that uses enzymes, supplements, and other factors in cancer management based on a theory that involves the use of pancreatic enzymes to help the body get rid of toxins that lead to cancer. Read about existing clinical data in this expert-reviewed summary.			CLICK HERE
1655	National Cancer Institute	Html	en	Antineoplastons (PDQ®)–Patient Version	Expert-reviewed information summary about antineoplastons as a treatment for people with cancer.	treatment 0.589875 cancer treatment 0.543159 cancer prevention 0.485229 Complementary Therapies Editorial 0.5308 certain cancer cells 0.51088 ongoing clinical trials 0.486889 human cancer cells 0.5323 Drug Administration 0.502832 Cancer Information Specialist 0.500618 cancer cells 0.568381 Cancer Information Service 0.566613 Dr. Burzynski permission 0.49482 PDQ cancer information 0.62364 Cancer Complementary 0.511148 CAM therapies 0.485534 non-randomized clinical trials 0.489986 treatment clinical trials 0.501989 National Cancer Institute 0.756717 clinical trials 0.926048 alternative medicine 0.557845 health care 0.482491 cancer information summary 0.569724 antineoplaston therapy 0.555366 alternative cancer therapies 0.505402	Federal Trade Commission 0.489849 National Institutes 0.483064 clinical trial 0.5421 new treatment 0.570175 CAM cancer research 0.494036 breast cancer prevention 0.482874 PDQ health 0.499386 cancer patients 0.558509 Cancer Care page 0.48497 S. R. Burzynski 0.50185 PDQ summary 0.490596 antineoplastons 0.689146 liver cancer cells 0.500913 Dr. Burzynski 0.778336 NCI PDQ cancer 0.539329 cancer information database 0.507025 cancer clinical trials 0.525243 colon cancer cells 0.502046 alternative therapies 0.539961 cancer information summaries 0.507383 possible cancer treatment 0.520373 Therapies Editorial Board 0.510662 cancer 0.84723	CLICK HERE
1933	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) en el embarazo (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de cáncer de seno (mama) en el embarazo.	estadio lllC 0.545921 procedimientos quizás 0.519027 estadio iv 0.622294 siguientes aspectos 0.528664 secciones llamadas lóbulos 0.542754 estadio lllB 0.547235 estadio lllA 0.548629 estadios ia 0.51696 ganglio linfático centinela 0.983407 Oncotype DX 0.522717 rayos x 0.518956 estadio ib 0.594193 prueba ayuda 0.551927 estadio ia 0.593122 pezón afección 0.529911 enlace drugs approved 0.522117 mama.ampliar cirugía 0.515861 causó hinchazón 0.517244 National Cancer Institute 0.51629 cuántos genes 0.520169	siguientes riesgos 0.513473 realidad células 0.541214 Instituto Nacional 0.528985 cuáles lesiones 0.51826 estadio iiia 0.547361 PDQ Tratamiento 0.523188 estadio iiic 0.745067 cáncer.ampliar mamografía 0.525478 estadio iia 0.550898 estadio llB 0.548944 estadio llA 0.550289 cuánta proteína 0.522295 siguientes casos 0.520535 Physician Data Query 0.558856 carcinoma lobulillar 0.602006 siguientes partes 0.548502 Breast Cancer 0.511799 mamas.ampliar carcinoma lobulillar 0.536157 siguientes pruebas 0.564002 vasos sanguíneos 0.630183	CLICK HERE
1985	National Cancer Institute	Html	es	Descripción del tratamiento de tumores de encéfalo y de médula espinal infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de tumores de encéfalo infantiles.	espinal infantiles.ampliar punción 0.671368 Organización Mundial 0.330213 células madre 0.838888 efectos secundarios meses 0.514746 siguientes aspectos 0.364078 vía oral 0.337627 encéfalo benignos 0.752955 PDQ Descripción 0.372391 efectos tardíos 0.660507 PDQ correspondiente 0.464116 tumor subtipo 0.432726 PDQ Efectos tardíos 0.450037 cáncer.ampliar aspiración 0.351047 Astrocitoma pilomixoide 0.336263 líquido cefalorraquídeo 0.817195 National Cancer Institute 0.340319 siguientes riesgos 0.328861	Instituto Nacional 0.370517 PDQ Tratamiento 0.975349 riesgo promedio 0.357023 presente sección 0.332468 siguientes signos 0.392336 nuevos tipos 0.34964 siguientes factores 0.362333 sistema nervioso central 0.653419 Physician Data Query 0.447911 gliomas astroblastoma 0.333341 pdq correspondiente tipo 0.412457 alto astrocitoma 0.3322 panel derecho 0.358602 espinal infantiles recién 0.572263 siguientes pruebas 0.390652 siguientes sumarios 0.353304 siguientes trastornos 0.347907	CLICK HERE
3419	National Cancer Institute	Html	es	Accidentes en plantas nucleares de electricidad y el riesgo de cáncer	Hoja informativa acerca de los riesgos del cáncer asociados con accidentes en plantas nucleares de electricidad. Incluye información para pacientes con cáncer que viven en una zona que puede haber sido afectada por un accidente en una planta nuclear.	Atomic Radiation 0.316837 United Nations 0.364483 accident―An epidemiological perspective 0.318721 Zablotska L 0.256274 assembly with scientific 0.304698 Chernobyl-related thyroid 0.281728 Nations Scientific Committee 0.309452 Ulanovsky AV 0.266554 case-control study 0.27312 Brenner AV 0.261036 altas dosis 0.502454 Health effects 0.274048 Cardis E 0.255707 Hatch M 0.715405 Instituto Nacional 0.562168 consecuente exposición 0.36176 related disorders among 0.314284 Chernobyl nuclear power 0.336354 causa cáncer 0.40919 Life Span Study 0.319261 Mykola DT 0.263715 Environmental Health Perspectives 0.308221 PubMed Abstract 0.845077 Finch SC 0.258873 Clinical Oncology 0.262917	Bouville A 0.255535 Chernobyl disaster 0.278477 Annex D 0.255425 Epidemiologic Reviews 0.264619 Amenaza Radiológica 0.258735 Individual thyroid 0.27723 workers from ukraine 0.329042 inhalar partículas 0.413261 Drozdovitch VV 0.265349 Ukraine related 0.277279 Ukranian-American study 0.271859 Contributions from long-lived 0.322355 quimioterapia sistémica 0.267728 Ionizing Radiation 0.316029 incident thyroid cancers 0.332215 Health Physics 0.266767 Chornobyl accident 0.268808 Ciencias Demográficas 0.257571 Belarus—part II 0.255864 thyroid cancers 0.38621 manejo médico 0.356172 medio ambiente 0.973732 Minenko VF 0.264858 Segunda Guerra Mundial 0.28983	CLICK HERE
3528	National Cancer Institute	Html	es	Dosis altas de vitamina C (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de dosis altas de vitamina C como tratamiento para personas con cáncer.	Natl Acad Sci 0.417663 ascorbic acid with 0.319941 Toxicol In Vitro 0.313376 Sin embargo 0.355085 exhibit antitumoral effects 0.313224 Pauling L 0.325518 Vitamin C 0.326615 vitamina c 0.479277 ascorbate enhanced chemosensitivity 0.326919 Instituto Nacional 0.312833 Cancer Res 0.390148 Chen Q 0.342148 patients with advanced 0.354811 supportive treatment 0.331337 Pharmacologic concentrations 0.313247 In vitro screening 0.313326 Med Oncol 0.314224 acid combination therapy 0.340469 with ascorbic acid 0.337638 Padayatty SJ 0.360813 Levine M 0.40315 patients with 0.414812 administración iv 0.317377 ascorbic acid 0.947894 estadio iv 0.317436	Pharmacologic doses 0.312587 voluntarios sanos 0.317063 intravenous ascorbic acid 0.330687 Proc Natl Acad 0.418979 benefit patients with 0.32288 Biol Blood Marrow 0.314132 acid therapy 0.32123 relapsed or refractory 0.319928 Nutr Cancer 0.315186 parenteral ascorbate enhanced 0.327964 National Cancer Institute 0.323649 ácido ascórbico iv 0.317065 Transl Med 0.334599 Intern Med 0.343771 Chemother Pharmacol 0.319656 Espey MG 0.344722 Sun AY 0.318432 Moertel CG 0.319183 Chem Biol Interact 0.340687 phase ii 0.326203 in vitro 0.345448 high-dose vitamin 0.327502 High-dose parenteral ascorbate 0.330109 ascorbic acid induces 0.316289	CLICK HERE
3889	National Cancer Institute	Html	en	Parents Who Have a Child with Cancer	Practical information for parents, when a child has cancer. Tips to help kids and parents cope and stay strong, together with answers to commonly asked questions from parents and children.	questions 0.35493 child life specialist 0.386505 child’s treatment 0.35347 child stay 0.349619 professional help 0.33179 health care team 0.725323 integrative medicine 0.336877 School-aged children 0.334822 illness children 0.331523 children 0.600994 social worker 0.38279 young children 0.353967 talk 0.366273 guide 0.345294 social media site 0.334677 individualized education plan 0.336753 Older children 0.332601 Child Fights 0.345493 child’s diagnosis 0.353024 child react 0.353407 physical changes 0.337307 friends 0.368904 child 0.906189 parents 0.404038 treatment 0.408118	Childhood Cancer section 0.347255 emotional changes 0.3435 mental health specialist 0.336601 Children’s Hospital 0.33095 Stay Strong section 0.335513 ways 0.385896 Integrative medicine practices 0.335837 hospital 0.356973 social media 0.340134 people 0.356129 primary care doctor 0.338718 way 0.329858 doctor 0.358256 child play 0.355719 school your child 0.347225 social media sites 0.338017 new medical information 0.336758 cancer 0.500444 information 0.37152 suggestions 0.340134 time 0.433424 family 0.348424 difficult time 0.340015 medical situation 0.335063	CLICK HERE
16256	National Cancer Institute	Html	en	Áreas de investigación	Sostener un progreso contra el cáncer requiere que se avance a través del continuo de investigación. Entérese de lo extenso que es el trabajo del NCI y de los programas que apoya el instituto para hacer avanzar la investigación oncológica.	National Cancer Institute 0.966549		CLICK HERE